Cargando…

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

Hepatocellular carcinoma (HCC) is the most common primary liver tumour (80–90%) and represents more than 5.7% of all cancers. Although in recent years the therapeutic options for these patients have increased, clinical results are yet unsatisfactory and the prognosis remains dismal. Clinical or mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faloppi, Luca, Bianconi, Maristella, Memeo, Riccardo, Casadei Gardini, Andrea, Giampieri, Riccardo, Bittoni, Alessandro, Andrikou, Kalliopi, Del Prete, Michela, Cascinu, Stefano, Scartozzi, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903134/ https://www.ncbi.nlm.nih.gov/pubmed/27314036 http://dx.doi.org/10.1155/2016/7196280

Ejemplares similares

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy
por: Faloppi, Luca, et al.
Publicado: (2016)

Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma
por: Bianconi, Maristella, et al.
Publicado: (2016)

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis
por: Bittoni, Alessandro, et al.
Publicado: (2015)

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
por: Faloppi, Luca, et al.
Publicado: (2015)

The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment
por: D’Anzeo, Marco, et al.
Publicado: (2014)

Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer
por: Giampieri, Riccardo, et al.
Publicado: (2015)

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2012)

Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach
por: Bittoni, Alessandro, et al.
Publicado: (2013)

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management
por: Scartozzi, Mario, et al.
Publicado: (2012)

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management
por: Del Prete, Michela, et al.
Publicado: (2015)

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab
por: Scartozzi, Mario, et al.
Publicado: (2012)

Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients
por: Scartozzi, Mario, et al.
Publicado: (2012)

Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients
por: Giampieri, Riccardo, et al.
Publicado: (2013)

Drugs for malaria: something old, something new, something borrowed
por: Hobbs, Charlotte, et al.
Publicado: (2011)

Something Old, Something New, Something Borrowed, Something Taboo: Interaction and Creativity in Humour
por: Maraev, Vladislav, et al.
Publicado: (2021)

Active pulmonary tuberculosis: something old, something new, something borrowed, something blue
por: Wetscherek, Maria T. A., et al.
Publicado: (2022)

Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients
por: Giampieri, Riccardo, et al.
Publicado: (2016)

Reinventing quantitative genetics for plant breeding: something old, something new, something borrowed, something BLUE
por: Bernardo, Rex
Publicado: (2020)

Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
por: Giampieri, Riccardo, et al.
Publicado: (2015)

Active Clinical Trials in Hepatic Encephalopathy: Something Old, Something New and Something Borrowed
por: Balzano, Tiziano
Publicado: (2023)

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue
por: Stroh, M, et al.
Publicado: (2015)

Antifungal Drug Discovery: Something Old and Something New
por: Butts, Arielle, et al.
Publicado: (2012)

Evaluation of liver fibrosis: “Something old, something new…”
por: Almpanis, Zannis, et al.
Publicado: (2016)

Diagnosing Diabetic Neuropathy: Something Old, Something New
por: Petropoulos, Ioannis N., et al.
Publicado: (2018)

Acute Flaccid Myelitis: Something Old and Something New
por: Morens, David M., et al.
Publicado: (2019)

Something Old, Something New, Something Borrowed"¦Comparative Effectiveness Research: A Policy Perspective
por: Subedi, Prasun, et al.
Publicado: (2011)

Something old or something new? Social health insurance in Ghana
por: Witter, Sophie, et al.
Publicado: (2009)

Something Old, Something New: The Modernization of the Older Americans Act
por: Bangerter, Lauren, et al.
Publicado: (2020)

Something Old, Something New, Something Borrowed; How the Thermoacidophilic Archaeon Sulfolobus solfataricus Responds to Oxidative Stress
por: Maaty, Walid S., et al.
Publicado: (2009)

Redox regulation of the Calvin–Benson cycle: something old, something new
por: Michelet, Laure, et al.
Publicado: (2013)

Minimal Residual Disease in Multiple Myeloma: Something Old, Something New
por: Bravo-Pérez, Carlos, et al.
Publicado: (2021)

Something old, something new: challenges and developments in Aspergillus niger biotechnology
por: Cairns, Timothy C., et al.
Publicado: (2021)

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
por: Faloppi, Luca, et al.
Publicado: (2014)

From Something Old to Something New: Functionalist Lessons for the Cognitive Science of Scientific Creativity
por: Sanches de Oliveira, Guilherme
Publicado: (2022)

Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents
por: Mitini-Nkhoma, Steven C., et al.
Publicado: (2021)

Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new
por: Rodeghiero, Francesco
Publicado: (2022)

Polyamines in Microalgae: Something Borrowed, Something New
por: Lin, Hung-Yun, et al.
Publicado: (2018)

AMPylation: Something Old is New Again
por: Woolery, Andrew R., et al.
Publicado: (2010)

VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
por: Scartozzi, M, et al.
Publicado: (2013)

Re-tooling critical care to become a better intensivist: something old and something new
por: Marini, John J
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h87sp1o82k6ivjn1nqjkumq8no